Patents by Inventor Duncan Taylor

Duncan Taylor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200061017
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Application
    Filed: October 31, 2019
    Publication date: February 27, 2020
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Patent number: 10507192
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: December 17, 2019
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Publication number: 20180263950
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Application
    Filed: May 18, 2018
    Publication date: September 20, 2018
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Patent number: 9999609
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: June 19, 2018
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Publication number: 20170000756
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Application
    Filed: September 16, 2016
    Publication date: January 5, 2017
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Patent number: 9464041
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Grant
    Filed: May 7, 2014
    Date of Patent: October 11, 2016
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Publication number: 20140243406
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Application
    Filed: May 7, 2014
    Publication date: August 28, 2014
    Applicant: SK Biopharmaceuticals, Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Patent number: 8741950
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Grant
    Filed: June 21, 2010
    Date of Patent: June 3, 2014
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Publication number: 20120142769
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Application
    Filed: June 21, 2010
    Publication date: June 7, 2012
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Patent number: 7793663
    Abstract: Disclosed is an earplug that includes a sound attenuating portion and a feature formed by laser ablation, wherein the feature comprises a cavity formed in a first end of the sound attenuating portion including a cylindrical shape extending into the sound attenuating portion, along a longitudinal axis of the sound attenuating portion, toward a second end of the sound attenuating portion opposite the first end, the earplug further comprising at least one of a cord, a stem, and a detectable insert disposed in the cavity.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: September 14, 2010
    Assignee: 3M Innovative Properties Company
    Inventor: Duncan Taylor
  • Patent number: 7370655
    Abstract: A method of forming an earplug is provided including removing a material of the earplug by laser ablation. An earplug is positioned proximate a laser, a portion of the earplug to be ablated is identified, the laser is activated so as to direct an emitted laser light toward the portion to be ablated, and the portion to be ablated is removed by laser ablation. The invention is also directed to an earplug including a feature formed by laser ablation.
    Type: Grant
    Filed: January 17, 2003
    Date of Patent: May 13, 2008
    Assignee: Cabot Safety Intermediate Corporation
    Inventor: Duncan Taylor
  • Publication number: 20080103146
    Abstract: Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. The compositions comprise a compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of at least about 5000. Examples of such compounds include reboxetine, and more preferably optically pure (S,S) enantiomer of reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 1, 2008
    Inventors: Erik Wong, Saeeduddin Ahmed, Robert Marshall, Robert McArthur, Duncan Taylor, Lars Birgerson, Pasquale Cetera
  • Publication number: 20080103147
    Abstract: Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. Examples of such compounds include reboxetine, and more particularly racemic reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 1, 2008
    Inventors: Erik Wong, Saeeduddin Ahmed, Robert Marshall, Robert McArthur, Duncan Taylor, Lars Birgerson, Pasquale Cetera
  • Publication number: 20080103145
    Abstract: Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. Examples of such compounds include reboxetine, and more particularly racemic reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 1, 2008
    Inventors: Erik Wong, Saeeduddin Ahmed, Robert Marshall, Robert McArthur, Duncan Taylor, Lars Birgerson, Pasquale Cetera
  • Publication number: 20080096890
    Abstract: Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. The compositions comprise a compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of at least about 5000. Examples of such compounds include reboxetine, and more preferably optically pure (S,S) enantiomer of reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
    Type: Application
    Filed: October 30, 2007
    Publication date: April 24, 2008
    Inventors: Erik Wong, Saeeduddin Ahmed, Robert Marshall, Robert McArthur, Duncan Taylor, Lars Birgerson, Pasquale Cetera
  • Publication number: 20080093158
    Abstract: Disclosed is an earplug that includes a sound attenuating portion and a feature formed by laser ablation, wherein the feature comprises a cavity formed in a first end of the sound attenuating portion including a cylindrical shape extending into the sound attenuating portion, along a longitudinal axis of the sound attenuating portion, toward a second end of the sound attenuating portion opposite the first end, the earplug further comprising at least one of a cord, a stem, and a detectable insert disposed in the cavity.
    Type: Application
    Filed: December 19, 2007
    Publication date: April 24, 2008
    Applicant: CABOT SAFETY INTERMEDIATE CORPORATION
    Inventor: Duncan Taylor
  • Publication number: 20070149527
    Abstract: This patent application describes the treatment of Addictive disorders, Psychoactive Substance Use disorders, Intoxication disorders, Inhalation disorders, Alcohol addiction, Tobacco addiction and or Nicotine addiction; and Attention Deficit Hyperactivity Disorder (ADHD); comprising administering a therapeutically effective, nontoxic dose of Reboxetine and derivatives and or pharmaceutically acceptable salts thereof to a patient.
    Type: Application
    Filed: February 15, 2007
    Publication date: June 28, 2007
    Applicant: PHARMACIA & UPJOHN COMPANY
    Inventors: Fred Hassan, John McCall, Duncan Taylor, Philip Von Voigtlander, Erik Ho Fong Wong
  • Publication number: 20060264436
    Abstract: Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. The compositions comprise a compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of at least about 5000. Examples of such compounds include reboxetine, and more preferably optically pure (S,S) enantiomer of reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
    Type: Application
    Filed: July 28, 2006
    Publication date: November 23, 2006
    Applicant: PHARMACIA & UPJOHN COMPANY
    Inventors: Erik Wong, Saeeduddin Ahmed, Robert Marshall, Robert McArthur, Duncan Taylor
  • Publication number: 20060160776
    Abstract: The present invention provides compositions and methods for the treatment of central nervous system damage in a subject. More particularly, the invention provides a combination therapy for the treatment of a central nervous system ischemic condition or a central nervous system traumatic injury comprising the administration to a subject of a cannabinoid agent in combination with a cyclooxygenase-2 selective inhibitor.
    Type: Application
    Filed: May 26, 2004
    Publication date: July 20, 2006
    Inventors: Diane Stephenson, Duncan Taylor
  • Publication number: 20060142289
    Abstract: Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. The compositions comprise a compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of at least about 5000. Examples of such compounds include reboxetine, and more preferably optically pure (S,S) enantiomer of reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
    Type: Application
    Filed: February 7, 2006
    Publication date: June 29, 2006
    Applicant: PHARMACIA & UPJOHN COMPANY
    Inventors: Erik Wong, Saeeduddin Ahmed, Robert Marshall, Robert McArthur, Duncan Taylor